Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
- PMID: 37686557
- PMCID: PMC10487098
- DOI: 10.3390/cancers15174281
Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
Abstract
In the last two decades, robotic-assisted thoracoscopic surgery (RATS) has gained popularity as a minimally invasive surgical (MIS) alternative to multi- and uniportal video-assisted thoracoscopic surgery (VATS). With this approach, the surgeon obviates the known drawbacks of conventional MIS, such as the reduced in-depth perception, hand-eye coordination, and freedom of motion of the instruments. Previous studies have shown that a robotic approach for operable lung cancer has treatment outcomes comparable to other MIS techniques such as multi-and uniportal VATS, but with less blood loss, a lower conversion rate to open surgery, better lymph node dissection rates, and improved ergonomics for the surgeon. The thoracic surgeon of the future is expected to perform more complex procedures. More patients will enter a multimodal treatment scheme making surgery more difficult due to severe inflammation. Furthermore, due to lung cancer screening programs, the number of patients presenting with operable smaller lung nodules in the periphery of the lung will increase. This, combined with the fact that segmentectomy is becoming an increasingly popular treatment for small peripheral lung lesions, indicates that the future thoracic surgeons need to have profound knowledge of segmental resections. New imaging techniques will help them to locate these lesions and to achieve a complete oncologic resection. Current robotic techniques exist to help the thoracic surgeon overcome these challenges. In this review, an update of the latest MIS approaches and nodule detection techniques will be given.
Keywords: lobectomy; minimally invasive surgery; nodule detection; non-small cell lung cancer; robotic-assisted thoracoscopic surgery; sublobar resections; video-assisted thoracoscopic surgery.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Trends of utilization and perioperative outcomes of robotic and video-assisted thoracoscopic surgery in patients with lung cancer undergoing minimally invasive resection in the United States.JTCVS Open. 2022 Aug 18;12:385-398. doi: 10.1016/j.xjon.2022.07.014. eCollection 2022 Dec. JTCVS Open. 2022. PMID: 36590738 Free PMC article.
-
Surgical Management of Lung Cancer: History, Evolution, and Modern Advances.Curr Oncol Rep. 2018 Nov 13;20(12):98. doi: 10.1007/s11912-018-0741-7. Curr Oncol Rep. 2018. PMID: 30421260 Review.
-
Comparison of uniportal robotic-assisted thoracic surgery pulmonary anatomic resections with multiport robotic-assisted thoracic surgery: a multicenter study of the European experience.Ann Cardiothorac Surg. 2023 Mar 31;12(2):102-109. doi: 10.21037/acs-2022-urats-27. Epub 2023 Mar 9. Ann Cardiothorac Surg. 2023. PMID: 37035654 Free PMC article.
-
The variability of practice in minimally invasive thoracic surgery for pulmonary resections.Thorac Surg Clin. 2008 Aug;18(3):235-47. doi: 10.1016/j.thorsurg.2008.06.002. Thorac Surg Clin. 2008. PMID: 18831498 Review.
-
Use of Robotics in Surgical Treatment of Non-small Cell Lung Cancer.Curr Treat Options Oncol. 2020 Aug 7;21(10):80. doi: 10.1007/s11864-020-00778-0. Curr Treat Options Oncol. 2020. PMID: 32767154 Review.
Cited by
-
Impact of pulmonary vein-first ligation during lobectomy on the postoperative survival and recurrence rates in patients with non-small cell lung cancer: a multicenter propensity score-matched study.Surg Today. 2024 Nov;54(11):1369-1378. doi: 10.1007/s00595-024-02852-8. Epub 2024 May 30. Surg Today. 2024. PMID: 38814330
-
Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions.J Clin Med. 2024 Jul 18;13(14):4189. doi: 10.3390/jcm13144189. J Clin Med. 2024. PMID: 39064229 Free PMC article. Review.
-
Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives.Cancers (Basel). 2025 Feb 14;17(4):652. doi: 10.3390/cancers17040652. Cancers (Basel). 2025. PMID: 40002247 Free PMC article. Review.
-
Evolution of Three-Dimensional Computed Tomography Imaging in Thoracic Surgery.Cancers (Basel). 2024 Jun 6;16(11):2161. doi: 10.3390/cancers16112161. Cancers (Basel). 2024. PMID: 38893279 Free PMC article. Review.
-
Extended lobectomy-how minimally invasive can we go?Transl Lung Cancer Res. 2024 May 31;13(5):961-964. doi: 10.21037/tlcr-24-296. Epub 2024 May 17. Transl Lung Cancer Res. 2024. PMID: 38854938 Free PMC article. No abstract available.
References
-
- Addeo A., Bianchi D., Minervini F. What is the role of surgery in stage III NSCLC in the era of Immunotherapy? Hematol. Med. Oncol. 2018;3:1–5.
-
- Lococo F., Sassorossi C., Mazzarella C., Vita E., Leoncini F., Martino A., Nachira D., Chiappetta M., Cesario A., Trisolini R., et al. Surgery after induction chemo or immunotherapy for locally advanced NSCLC. Curr. Chall. Thorac. Surg. 2020;2:42. doi: 10.21037/ccts-20-78. - DOI
Publication types
LinkOut - more resources
Full Text Sources